# Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care

> **NCT03237819** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 74 (actual)

## Conditions studied

- Thrombotic Thrombocytopenic Purpura

## Interventions

- **DRUG:** Sulfate, Magnesium
- **DRUG:** Placebo - Concentrate

## Key facts

- **NCT ID:** NCT03237819
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-27
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03237819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03237819, "Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03237819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*